Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Epigenetic aging in psychiatry: clinical implications and therapeutic opportunities
    Published on 2022-07-22
    3 years ago
  • IN MEMORIAM John Gary Csernansky 1954–2022
    Published on 2022-07-22
    3 years ago
  • The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder
    Published on 2022-07-20
    3 years ago
  • Targeted and transient opening of the blood brain barrier in discrete neurocircuits and brain regions
    Published on 2022-07-18
    3 years ago
  • Prenatal opioid exposure inhibits microglial sculpting of the dopamine system selectively in adolescent male offspring
    Published on 2022-07-14
    3 years ago
  • Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice
    Published on 2022-07-11
    3 years ago
  • In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study
    Published on 2022-07-11
    3 years ago
« Previous 1 … 128 129 130 131 132 … 143 Next »
Journal of Psychopharmacology
  • The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction
    Published on 2018-12-11
    7 years ago
  • Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress
    Published on 2018-10-16
    7 years ago
  • Acute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults
    Published on 2018-10-15
    7 years ago
  • A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
    Published on 2018-10-01
    7 years ago
  • Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants
    Published on 2018-09-27
    7 years ago
  • Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats
    Published on 2018-09-27
    7 years ago
  • Anhedonia and depression severity dissociated by dmPFC resting-state functional connectivity in adolescents
    Published on 2018-09-27
    7 years ago
« Previous 1 … 128 129 130 131 132 … 134 Next »
European Neuropsychopharmacology
  • P.754 Effect of osteopathic treatment as adjunct therapy in cervical dystonia patients treated with incobotulinumtoxinA
    Published on 2020-11-25
    5 years ago
  • P.762 KN-93, an inhibitor of ca++/calmodulin-dependent protein kinase, inhibits neuronal cell viability in an in vitro Alzheimer’s disease model
    Published on 2020-11-25
    5 years ago
  • P.784 Comparison of stimulus dose determination methods in electroconvulsive therapy: possible advantages and disadvantages of dose titration protocol and half-age method
    Published on 2020-11-25
    5 years ago
  • P.785 A possible role of endothelial dysfunction proteins in the pathogenesis of the bipolar disorder
    Published on 2020-11-25
    5 years ago
  • P.742 Atorvastatin increases fear processing in healthy participants
    Published on 2020-11-25
    5 years ago
  • P.763 Systematic review of clinical evidence for the use of nonpharmacological and pharmacological strategies to manage delirium
    Published on 2020-11-25
    5 years ago
  • P.861Gender-specific involvement of Methyl-CpG binding protein 2 in vulnerability to stress: evidence from a healthy cohort
    Published on 2020-11-25
    5 years ago
« Previous 1 … 128 129 130 131 132 … 153 Next »

   Pharma Pub